Hilltop Holdings’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.15M | Sell |
3,424
-5,744
| -63% | -$5.82M | 0.28% | 83 |
|
|
2025
Q4 | $9.85M | Sell |
9,168
-7,312
| -44% | -$6.99M | 0.58% | 27 |
|
|
2025
Q3 | $12.6M | Buy |
16,480
+8,154
| +98% | +$6.07M | 0.67% | 24 |
|
|
2025
Q2 | $6.49M | Sell |
8,326
-432
| -5% | -$336K | 0.42% | 50 |
|
|
2025
Q1 | $7.23M | Buy |
8,758
+705
| +9% | +$587K | 0.45% | 42 |
|
|
2024
Q4 | $6.22M | Buy |
8,053
+725
| +10% | +$600K | 0.39% | 55 |
|
|
2024
Q3 | $6.49M | Buy |
7,328
+3,972
| +118% | +$3.57M | 0.41% | 55 |
|
|
2024
Q2 | $3.04M | Sell |
3,356
-1,025
| -23% | -$820K | 0.35% | 63 |
|
|
2024
Q1 | $3.41M | Buy |
4,381
+218
| +5% | +$155K | 0.35% | 71 |
|
|
2023
Q4 | $2.43M | Sell |
4,163
-158
| -4% | -$92.2K | 0.28% | 105 |
|
|
2023
Q3 | $2.32M | Buy |
4,321
+277
| +7% | +$143K | 0.27% | 99 |
|
|
2023
Q2 | $1.9M | Buy |
4,044
+375
| +10% | +$157K | 0.23% | 113 |
|
|
2023
Q1 | $1.26M | Sell |
3,669
-186
| -5% | -$62.7K | 0.17% | 130 |
|
|
2022
Q4 | $1.41M | Buy |
3,855
+725
| +23% | +$257K | 0.18% | 129 |
|
|
2022
Q3 | $1.01M | Sell |
3,130
-425
| -12% | -$135K | 0.14% | 151 |
|
|
2022
Q2 | $1.15M | Buy |
3,555
+316
| +10% | +$94.9K | 0.15% | 140 |
|
|
2022
Q1 | $927K | Sell |
3,239
-325
| -9% | -$83.6K | 0.1% | 177 |
|
|
2021
Q4 | $984K | Sell |
3,564
-313
| -8% | -$79.3K | 0.1% | 187 |
|
|
2021
Q3 | $896K | Buy |
3,877
+375
| +11% | +$92.6K | 0.1% | 203 |
|
|
2021
Q2 | $804K | Buy |
3,502
+165
| +5% | +$33.1K | 0.09% | 216 |
|
|
2021
Q1 | $623K | Buy |
3,337
+476
| +17% | +$93.1K | 0.08% | 241 |
|
|
2020
Q4 | $483K | Buy |
2,861
+1,349
| +89% | +$201K | 0.07% | 270 |
|
|
2020
Q3 | $224K | Buy |
1,512
+249
| +20% | +$38.5K | 0.04% | 376 |
|
|
2020
Q2 | $208K | Buy |
+1,263
| New | +$194K | 0.04% | 359 |
|
|
2018
Q2 | – | Sell |
-3,732
| Closed | -$288K | – | 446 |
|
|
2018
Q1 | $288K | Buy |
+3,732
| New | +$300K | 0.05% | 318 |
|
|
2015
Q1 | – | Sell |
-6,586
| Closed | -$454K | – | 338 |
|
|
2014
Q4 | $454K | Sell |
6,586
-348
| -5% | -$23.5K | 0.16% | 125 |
|
|
2014
Q3 | $450K | Buy |
6,934
+791
| +13% | +$50.1K | 0.21% | 121 |
|
|
2014
Q2 | $382K | Buy |
6,143
+1,033
| +20% | +$61.6K | 0.18% | 140 |
|
|
2014
Q1 | $301K | Buy |
+5,110
| New | +$285K | 0.15% | 163 |
|
Other funds holding LLY
VCM
VPM
Hilltop Holdings's LLY Position: Q1 2026 in Review
Hilltop Holdings reduced its Eli Lilly (LLY) stake by 63% in Q1 2026, selling an estimated $5.82M and leaving 3,424 shares worth $3.15M. The position accounts for 0.28% of the portfolio, ranked #83.
Hilltop Holdings first reported a position in LLY in Q1 2014 and has held it in 29 quarters since. The position peaked at $12.6M in Q3 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Hilltop Holdings held 3,424 shares of Eli Lilly worth $3.15M as of Q1 2026.
- Hilltop Holdings sold 5,744 Eli Lilly shares in Q1 2026, an estimated $5.82M.
- Eli Lilly made up 0.28% of Hilltop Holdings's portfolio in Q1 2026, its #83 holding.
- Hilltop Holdings first reported a position in Eli Lilly in Q1 2014 and has held it in 29 quarters since.
- Hilltop Holdings's Eli Lilly position peaked at $12.6M in Q3 2025.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Hilltop Holdings's 13F filing for Q1 2026, filed 14 May 2026.